38 related articles for article (PubMed ID: 1339930)
1. The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial.
Haugen M; Magnussen K; Aarsland TE; Nissen-Meyer LSH; Strand TA
Trials; 2024 Mar; 25(1):175. PubMed ID: 38468338
[TBL] [Abstract][Full Text] [Related]
2. Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial.
Mortier A; Khoudary J; van Dooslaer de Ten Ryen S; Lannoy C; Benoit N; Antoine N; Copine S; Van Remoortel H; Vandekerckhove P; Compernolle V; Deldicque L
Vox Sang; 2024 Feb; 119(2):134-143. PubMed ID: 37997609
[TBL] [Abstract][Full Text] [Related]
3. Very-high frequency plasmapheresis and donor health-absence of evidence is not equal to evidence of absence.
Van Remoortel H; van den Hurk K; Compernolle V; O'Leary P; Tiberghien P; Erikstrup C
Transfusion; 2023 Dec; 63(12):2358-2361. PubMed ID: 37982361
[No Abstract] [Full Text] [Related]
4. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
[TBL] [Abstract][Full Text] [Related]
5. [The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)].
Herrmann BL
MMW Fortschr Med; 2020 Aug; 162(14):44-46. PubMed ID: 32780376
[TBL] [Abstract][Full Text] [Related]
6. Plasma proteins and lymphocyte phenotypes in long-term plasma donors.
Lewis SL; Kutvirt SG; Bonner PN; Simon TL
Transfusion; 1994 Jul; 34(7):578-85. PubMed ID: 8053039
[TBL] [Abstract][Full Text] [Related]
7. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
[TBL] [Abstract][Full Text] [Related]
8. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
[TBL] [Abstract][Full Text] [Related]
9. [Serum levels of IgG, IgA, IgM, blood proteins and various lysosomal enzymes in donors after repeated plasmapheresis].
Chocha A; Nenycz A; Szklarska W
Wiad Lek; 1990 Oct 1-15; 43(19-20):949-52. PubMed ID: 2127490
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study of the antibody level in confirmed patients with COVID-19 after discharge].
Shen G; Yang G; Zeng ZY; Hu Y; Li Q; Liu ZG; Fu HY; Hu JY; Zhu P; Huang JH; Lu QQ; Shi SJ; He Y; Xie XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Dec; 54(12):1448-1452. PubMed ID: 33333665
[No Abstract] [Full Text] [Related]
11. Value and Validity of Coronavirus Antibody Testing.
Mahajan A; Manchikanti L
Pain Physician; 2020 Aug; 23(4S):S381-S390. PubMed ID: 32942795
[TBL] [Abstract][Full Text] [Related]
12. The effect of plasmapheresis on blood pressure in voluntary plasma donors.
Rosa-Bray M; Wisdom C; Marier JF; Mouksassi MS; Wada S
Vox Sang; 2015 Jan; 108(1):11-7. PubMed ID: 25169580
[TBL] [Abstract][Full Text] [Related]
13. [The effect of plasmapheresis on IgG and albumin].
Flesland O; Halvorsen R; Solheim BG; Orjasaeter H
Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1936-7. PubMed ID: 2363163
[TBL] [Abstract][Full Text] [Related]
14. Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study.
Moog R; Laitinen T; Taborski U
Transfus Med Hemother; 2022 Sep; 49(5):271-279. PubMed ID: 37969863
[TBL] [Abstract][Full Text] [Related]
15. Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection.
De Giorgi V; West KA; Henning AN; Chen LN; Holbrook MR; Gross R; Liang J; Postnikova E; Trenbeath J; Pogue S; Scinto T; Alter HJ; Cantilena CC
J Infect Dis; 2021 Oct; 224(8):1294-1304. PubMed ID: 34089610
[TBL] [Abstract][Full Text] [Related]
16. Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.
Pittman PR; Leitman SF; Oro JG; Norris SL; Marano NM; Ranadive MV; Sink BS; McKee KT
Clin Diagn Lab Immunol; 2005 Jun; 12(6):713-21. PubMed ID: 15939745
[TBL] [Abstract][Full Text] [Related]
17. Serum IgG and IgM levels in new and regular long-term plasmapheresis donors.
Burgin M; Hopkins G; Moore B; Nasser J; Richardson A; Minchinton R
Med Lab Sci; 1992 Dec; 49(4):265-70. PubMed ID: 1339930
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
